DocSym
β
Searchsearch
Search
(C83.4) Иммунобластная (диффузная)
More details coming soon
3 114 017 in individuals diagnosis иммунобластная (диффузная) confirmed
213 135 deaths with diagnosis иммунобластная (диффузная)
7% mortality rate associated with the disease иммунобластная (диффузная)
Diagnosis иммунобластная (диффузная) is diagnosed Men are 11.42% more likely than Women
1 734 759
Men receive the diagnosis иммунобластная (диффузная)
107 180 (6.2 %)Died from this diagnosis.
100
95
90
85
80
75
70
65
60
55
50
45
40
35
30
25
20
15
10
5
0
1 379 258
Women receive the diagnosis иммунобластная (диффузная)
105 955 (7.7 %)Died from this diagnosis.
Risk Group for the Disease иммунобластная (диффузная) - Men and Women aged 65-69
In Men diagnosis is most often set at age 0-95+
Less common in men the disease occurs at Age 0-1Less common in women the disease occurs at Age 0-1
In Women diagnosis is most often set at age 0-95+
Disease Features иммунобластная (диффузная)
Absence or low individual and public risk
Иммунобластная (диффузная) - what does this mean
Immunoblastic (diffuse) disease is an aggressive type of lymphoma in which malignant b cells accumulate in lymph nodes, the spleen, and other organs. it is characterized by the presence of large, abnormal b cells with a high rate of cell division and an increased number of plasma cells.
What happens during the disease - иммунобластная (диффузная)
Immunoblastic (diffuse) disease is a type of non-hodgkin lymphoma which is caused by an abnormal proliferation of b-lymphocytes. the malignant cells of this type of lymphoma are characterized by the presence of a large nucleus and an abundant cytoplasm. this proliferation of malignant cells is caused by a dysfunction of the immune system, which leads to an overproduction of b-lymphocytes and an inability of the immune system to control their growth. as a result, these malignant cells accumulate in the lymph nodes and other organs, leading to the symptoms associated with this type of lymphoma.
Clinical Pattern
More details coming soon
How does a doctor diagnose
More details coming soon
Treatment and Medical Assistance
More details coming soon
14 Days of Hospitalization Required
Average Time for Outpatient Care Not Established
Иммунобластная (диффузная) - Prevention
Prevention of immunoblastic (diffuse) disease involves avoiding exposure to environmental toxins, maintaining a healthy lifestyle, getting regular exercise, eating a balanced diet, and getting adequate rest. vaccines may also be available to protect against certain forms of the disease. additionally, regular screening for early detection and prompt treatment of any symptoms can help reduce the risk of developing more serious complications.